SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001116502-09-001725
Filing Date
2009-11-10
Accepted
2009-11-10 10:34:42
Documents
3
Period of Report
2009-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT slxcf_8k.htm 8-K/A 10432
2 PRESS RELEASE slxcf_ex991.htm EX-99.1 103268
3 slxcf_ex991002.gif GRAPHIC 22256
  Complete submission text file 0001116502-09-001725.txt   146064
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-31198 | Film No.: 091170691
SIC: 2834 Pharmaceutical Preparations